Obesity is having an excessive amount of body fat in relation to lean body mass that may impair health.
The primary cause is an energy imbalance between calories consumed and expended.
Treatment goals include to lose 5-10% of body weight or 0.5-1 kg (1-2 lb)/week for 6 months and regain of <3 kg in 2 years and sustained reduction of waist circumference of at least 4 cm.
Strategies are aiming for realistic goals and a multidisciplinary approach that is a combination of dietary change, physical activity and behavioral modification.
Among women with severe obesity, undergoing bariatric (Roux-en-Y gastric bypass) surgery prior to conception was associated with a reduced risk of major birth defects in their infants, according to a matched cohort study conducted in Sweden.
The LITE (Lifestyle Intervention for Teenagers) programme, a family-based behavioural lifestyle intervention, demonstrates acceptability, feasibility as well as short-term clinical effectiveness in improving some clinical outcomes and adolescents’ perception of family support, according to a Singapore study.
There is an unmistakable presence of comorbidities in primary school children who are obese, according to a study. Lifestyle interventions have a greater effect on such comorbidities in primary than in secondary school children, which underscores the necessity of early interventions.
Individuals with obesity are at an elevated risk of developing infections, particularly that of the skin in both men and women, and those of the gastrointestinal and urinary tracts and sepsis in women only, according to a study.
Obesity at any age in adulthood doubles the risk of having poor physical functioning in midlife, with body mass index gains over much of the life course and prolonged exposure to obesity contributing to the risk, according to a study.
Teens with severe obesity need not wait until they are adults to undergo Roux-en-Y gastric bypass, with 5-year follow-up data from a recent study showing that the bariatric procedure leads to substantial weight loss that is similar in magnitude in adolescents and adults.
The risk of nonvertebral fractures is dependent on type of bariatric surgery, with a higher risk in patients with severe obesity who undergo Roux-en-Y gastric bypass (RYGB) compared with adjustable gastric banding (AGB), according to a recent retrospective study.
Laparoscopic sleeve gastrectomy is useful for treating severe obesity in adolescents with cognitive impairment or developmental disability, according to a study, suggesting that bariatric surgery should be considered for young people, regardless of intellectual ability.
One anastomosis gastric bypass is as effective as the standard Roux-en-Y procedure in terms of weight loss and metabolic improvements 24 months after the surgery, according to the results of the open-label YOMEGA trial.
Taisho Pharmaceutical launches Lusefi®, an oral anti-diabetic medication for type 2 diabetes mellitus (T2DM). The medication is expected to lower blood glucose and provide adequate glycaemic control, serving as a new alternative prescription for T2DM. Lusefi, with its active ingredient luseogliflozin hydrate, is available in the form of 2.5 mg and 5 mg tablets.
At a recent Abbott lunch symposium held in conjunction with the joint 12th International Diabetes FederationWestern Pacific Region Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in KualaLumpur, Professor Shashank R. Joshi extensively discussed the issue of diabetes in obesity and the role of nutritionalintervention in addressing this growing problem.
Dapagliflozin is able to delay renal disease progression among patients with type 2 diabetes, even in those with normal kidney function, according to a study presented at the recently concluded Kidney Week 2019 of the American Society of Nephrology (ASN 2019).
In pancreatic cancer patients undergoing chemotherapy, the presence of diabetes mellitus is associated with reduced survival and larger tumour, as well as with increased risk of death after treatment, according to a meta-analysis.